How to evaluate a peptide claim

Four questions that separate a claim worth investigating from a claim that only sounds specific.

Why this matters

• Most people do not first meet a peptide in a journal. They meet it in a conversation, a video, or a page written by someone with something to sell, and the claim is usually specific enough to sound checkable and vague enough that it isn't. That is an uncomfortable position for a thoughtful person to be in.
• Having a short, repeatable method turns that discomfort into something manageable. It also means you can bring a physician a precise question instead of a headline, which tends to produce a far more useful conversation.

Start with the exact substance, not the category

Claims frequently attach to a family rather than a molecule: peptides help recovery, peptides support metabolism. A family is not a substance. Two molecules that share the label can have entirely different human data, entirely different regulatory status, and entirely different safety considerations.

So the first question is which single substance is being discussed, named precisely. If a claim cannot survive being pinned to one named molecule, there was never anything specific to check, and that in itself is a useful finding rather than a dead end.

Then pin down the outcome that was actually measured

Impressive-sounding claims often rest on a substitute for the thing you care about. A marker moving in blood, a change visible under a microscope, or a score on a laboratory task are all legitimate research measurements, and none of them is the same as feeling better, healing faster, or living longer.

Ask what was measured, in whom, over what period, and compared with what. A result with no comparison group tells you what happened, not what would have happened anyway. Time matters too: many things people attribute to an intervention improve on their own over the same weeks.

Notice what the claim quietly leaves out

Three omissions recur. The first is population: results in trained young athletes, in people with a specific diagnosis, or in animals are frequently presented as though they generalise to everyone. The second is magnitude: an effect can be real, statistically detectable, and far too small to notice in daily life. The third is harm, which is simply absent from most marketing.

Personal testimony deserves particular care, not because people are lying, but because a single account cannot separate the intervention from everything else that changed. Most people who try something new also sleep, eat, train or manage stress differently at the same time.

Check who is speaking, and what the law expects of them

Advertising that makes a health claim in the United States is expected to be truthful, not misleading, and supported by competent and reliable scientific evidence. The Federal Trade Commission publishes guidance describing what that support looks like, and it is a much higher bar than a plausible story or a cited abstract that measured something else.

This is not a reason to dismiss everyone with a commercial interest, GOAL.MD included. It is a reason to check whether a specific claim is accompanied by evidence about that specific substance and that specific outcome, and to treat the absence of such evidence as meaningful rather than accidental.

Definitions

Surrogate endpoint

A measurement used as a stand-in for the outcome that matters, such as a blood marker used in place of how a person actually functions.

Surrogates can move without the real outcome following, so a claim built on one is weaker than it sounds.

Control group

A comparison group that does not receive the intervention, allowing the effect of time, expectation and routine care to be separated out.

Competent and reliable scientific evidence

The standard of substantiation US advertisers are expected to hold for health claims, described in FTC guidance.

Effect size

How large a measured difference is, as distinct from whether one was detected at all.

What is reasonably established

• US health-claim advertising is expected to be truthful, not misleading, and supported by competent and reliable scientific evidence.
• Controlled comparison is what allows a measured change to be attributed to an intervention rather than to time or expectation.
• Surrogate measurements and clinical outcomes are different things, and a change in one does not establish a change in the other.

What is not established

• That an effect demonstrated in one population applies to a different population.
• That a statistically detectable effect is large enough for a person to notice.
• That the absence of reported harm in marketing material means harm was looked for.

Safety context

• A claim that omits risk entirely has not established that risk is absent; it has usually established that risk was not discussed.
• Bring the exact product name and the exact claim to a physician rather than a summary, since the specifics are what make evaluation possible.
• Suspected harms can be reported to the FDA through MedWatch.

Regulatory framing

A claim's regulatory context changes its meaning. A statement about a branded product's approved indication has been reviewed by the FDA. A statement about off-label use of that same product has not. A statement about a compounded preparation or an investigational substance sits outside the approval framework entirely, and physician involvement does not move it inside.

Frequently asked questions

A clinic cited a real published study. Isn't that enough?

It depends entirely on whether the study examined the same substance, the same outcome, and a comparable population. A genuine citation that measured something else is one of the most common ways a weak claim is made to look substantiated.

How much should I weigh personal testimonials?

Treat them as descriptions of an experience rather than as evidence of cause. One account cannot separate the intervention from everything else that changed at the same time, and the accounts that did not go well are rarely the ones you see.

Is a claim about how something works the same as a claim about what it does?

No, and the two are routinely blended. A mechanism describes a plausible route to an effect; only measurement in people establishes that the effect occurred.

Sources

• Health Products Compliance Guidance — U.S. Federal Trade Commission
• Learn About Studies — ClinicalTrials.gov, U.S. National Library of Medicine
• Understanding Unapproved Use of Approved Drugs "Off Label" — U.S. Food and Drug Administration

This page is educational. It is not medical advice, not a prescription, and nothing here can be ordered. Compounded preparations are not FDA-approved. To ask a physician about your own situation, visit goal.md/peptides/connect or call or text 314-907-3103.

Medically reviewed by Michael Fitch, MD. Compliance review by Michael Mimlitz, MD. Last reviewed 2026-08-15.